Duopharma Biotech Berhad (7148.KL)

MYR 1.16

(0.0%)

Long Term Debt Summary of Duopharma Biotech Berhad

  • Duopharma Biotech Berhad's latest annual long term debt in 2023 was 480.9 Million MYR , up 62.18% from previous year.
  • Duopharma Biotech Berhad's latest quarterly long term debt in 2024 Q2 was 472.79 Million MYR , down -0.86% from previous quarter.
  • Duopharma Biotech Berhad reported annual long term debt of 296.52 Million MYR in 2022, down -1.25% from previous year.
  • Duopharma Biotech Berhad reported annual long term debt of 300.27 Million MYR in 2021, up 18.25% from previous year.
  • Duopharma Biotech Berhad reported quarterly long term debt of 476.88 Million MYR for 2024 Q1, down -0.84% from previous quarter.
  • Duopharma Biotech Berhad reported quarterly long term debt of 272.27 Million MYR for 2023 Q2, down -4.13% from previous quarter.

Annual Long Term Debt Chart of Duopharma Biotech Berhad (2023 - 2006)

Historical Annual Long Term Debt of Duopharma Biotech Berhad (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 480.9 Million MYR 62.18%
2022 296.52 Million MYR -1.25%
2021 300.27 Million MYR 18.25%
2020 253.94 Million MYR 80.67%
2019 140.55 Million MYR 15.54%
2018 121.65 Million MYR 33.46%
2017 91.14 Million MYR -0.71%
2016 91.79 Million MYR -11.57%
2015 103.8 Million MYR 0.0%
2014 - MYR 0.0%
2013 - MYR 0.0%
2012 - MYR -100.0%
2011 2.08 Million MYR -80.01%
2010 10.41 Million MYR 13.53%
2009 9.17 Million MYR 0.0%
2008 - MYR 0.0%
2007 - MYR 0.0%
2006 - MYR 0.0%

Peer Long Term Debt Comparison of Duopharma Biotech Berhad

Name Long Term Debt Long Term Debt Difference
Kotra Industries Berhad -11.14 Million MYR 4413.409%